{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T06:18:25Z","timestamp":1704694705766},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s12325-012-0063-3","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T12:56:38Z","timestamp":1352984198000},"page":"979-991","source":"Crossref","is-referenced-by-count":7,"title":["Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study"],"prefix":"10.1007","volume":"29","author":[{"given":"Ana I.","family":"S\u00e1nchez-Fructuoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 V.","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto J.","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda I.","family":"Troya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Bernis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 F.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,13]]},"reference":[{"key":"63_CR1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e3181a170b7","volume":"87","author":"Y. Vanrenterghem","year":"2009","unstructured":"Vanrenterghem Y. Anemia after kidney transplantation. Transplantation. 2009;87:1265\u20131267.","journal-title":"Transplantation"},{"key":"63_CR2","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2215\/CJN.04641007","volume":"3","author":"D. Chhabra","year":"2008","unstructured":"Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol. 2008;3:1168\u20131174.","journal-title":"Clin J Am Soc Nephrol"},{"key":"63_CR3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1600-6143.2006.01727.x","volume":"7","author":"M.Z. Molnar","year":"2007","unstructured":"Molnar MZ, Czira M, Ambrus C, et al. Anemia is associated with mortality in kidney-transplanted patients-a prospective cohort study. Am J Transplant. 2007;7:818\u2013824.","journal-title":"Am J Transplant"},{"key":"63_CR4","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1093\/ndt\/gfl457","volume":"21","author":"W.C. Winkelmayer","year":"2006","unstructured":"Winkelmayer WC, Chandraker A, Alan BM, Kramar R, Sunder-Plassmann G. A prospective study of anaemia and long-term outcomes in kidney transplant recipients. Nephrol Dial Transplant. 2006;21:3559\u20133566.","journal-title":"Nephrol Dial Transplant"},{"key":"63_CR5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1681\/ASN.V1341084","volume":"13","author":"C. Rigatto","year":"2002","unstructured":"Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13:1084\u20131090.","journal-title":"J Am Soc Nephrol"},{"key":"63_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/01.ASN.0000043141.67989.39","volume":"14","author":"C. Rigatto","year":"2003","unstructured":"Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 2003;14:462\u2013468.","journal-title":"J Am Soc Nephrol"},{"key":"63_CR7","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1053\/j.ajkd.2006.03.010","volume":"47","author":"N. K. Foundation. KDOQI","year":"2006","unstructured":"KDOQI, National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis. 2006;47:S11\u2013S145.","journal-title":"Am J Kidney Dis"},{"key":"63_CR8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1111\/j.1742-1241.2006.01214.x","volume":"60","author":"A.L. Francisco de","year":"2006","unstructured":"de Francisco AL, Sulowicz W, Klinger M, et al; BA16260 Study Investigators. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study. Int J Clin Pract. 2006;60:1687\u20131696.","journal-title":"Int J Clin Pract"},{"key":"63_CR9","first-page":"306","volume":"67","author":"R. Provenzano","year":"2007","unstructured":"Provenzano R, Besarab A, Macdougall IC, et al; BA16528 Study Investigators. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study. Clin Nephrol. 2007;67:306\u2013317.","journal-title":"Clin Nephrol"},{"key":"63_CR10","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.00480107","volume":"3","author":"I.C. Macdougall","year":"2008","unstructured":"Macdougall IC, Walker R, Provenzano R, et al; ARCTOS Study Investigators. C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Clin J Am Soc Nephrol. 2008;3:337\u2013347.","journal-title":"Clin J Am Soc Nephrol"},{"key":"63_CR11","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1093\/ndt\/gfr160","volume":"26","author":"S.D. Roger","year":"2011","unstructured":"Roger SD, Locatelli F, Woitas RP, et al. C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis. Nephrol Dial Transplant. 2011;26:3980\u20133986.","journal-title":"Nephrol Dial Transplant"},{"key":"63_CR12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1185\/03007991003666652","volume":"26","author":"D. Fliser","year":"2010","unstructured":"Fliser D, Kleophas W, Dellanna F, et al. Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study. Curr Med Res Opin. 2010;26:1083\u20131089.","journal-title":"Curr Med Res Opin"},{"key":"63_CR13","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1093\/ndt\/gfq305","volume":"25","author":"F. Carrera","year":"2010","unstructured":"Carrera F, Lok CE, de Francisco A, et al; PATRONUS Investigators. Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant. 2010;25:4009\u20134017.","journal-title":"Nephrol Dial Transplant"},{"key":"63_CR14","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1093\/ndt\/gfn320","volume":"23","author":"B. Canaud","year":"2008","unstructured":"Canaud B, Mingardi G, Braun J, et al; STRIATA Study Investigators. Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Nephrol Dial Transplant. 2008;23:3654\u20133661.","journal-title":"Nephrol Dial Transplant"},{"key":"63_CR15","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(07)61599-2","volume":"370","author":"N.W. Levin","year":"2007","unstructured":"Levin NW, Fishbane S, Canedo FV, et al; MAXIMA Study Investigators. Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA). Lancet. 2007;370:1415\u20131421.","journal-title":"Lancet"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1185\/030079907X182103","volume":"23","author":"F. Locatelli","year":"2007","unstructured":"Locatelli F, Villa G, de Francisco AL, et al; BA16286 Study Investigators. Effect of a continuous erythropoietin receptor activator (C.E.R.A.) on stable haemoglobin in patients with CKD on dialysis: once monthly administration. Curr Med Res Opin. 2007;23:969\u2013979.","journal-title":"Curr Med Res Opin"},{"key":"63_CR17","first-page":"36","volume":"11","author":"A. Carre\u00f1o","year":"2011","unstructured":"Carre\u00f1o A, Campistol JM, Arias M, Morales JM, Pallardo L, Franco A. A randomised, multicenter, phase IIIb clinical trial to evaluate efficacy and safety of C.E.R.A. once a month versus darbepoetin alfa in renal transplant recipients with chronic renal anaemia (TIVOLI Study Group). Am J Transplant. 2011;11:36.","journal-title":"Am J Transplant"},{"key":"63_CR18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000321486","volume":"30","author":"R. Minutolo","year":"2010","unstructured":"Minutolo R, Zamboli P, Chiodini P, et al. Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients. Blood Purif. 2010;30:186\u2013194.","journal-title":"Blood Purif"},{"key":"63_CR19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5414\/CN106847","volume":"76","author":"J.F. Mann","year":"2011","unstructured":"Mann JF, de Francisco A, Nassar G, Canaud B. Fewer dose changes with once-monthly C.E.R.A. in patients with chronic kidney disease. Clin Nephrol. 2011;76:9\u201315.","journal-title":"Clin Nephrol"},{"key":"63_CR20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5414\/CNP73094","volume":"73","author":"F. Locatelli","year":"2010","unstructured":"Locatelli F, Mann JF, Aldigier JC, et al. C.E.R.A. safety profile: a pooled analysis in patients with chronic kidney disease. Clin Nephrol. 2010;73:94\u2013103.","journal-title":"Clin Nephrol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0063-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-012-0063-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-012-0063-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T10:18:57Z","timestamp":1643624337000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-012-0063-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s12325-012-0063-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}